insights_auto
Why is JSPR down 12,15%?
Dive Deeperchevron_right
JSPR:NASDAQ
Jasper Therapeutics Inc
US$10,34
arrow_downward
-12,15%(-1,43) 1D
17 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JSPR...
Open
US$11,96
High
US$12,00
Low
US$9,25
Mkt. cap
11,47 ລ້ານ
Avg. vol.
21,07 ພັນ
Volume
49,07 ພັນ
52-wk high
US$72,60
52-wk low
US$9,25
EPS
US$-47,40
Beta
3,30
Shares outstanding
1,11 ລ້ານ
No. of employees
22
Open
US$11,96
High
US$12,00
Low
US$9,25
Mkt. cap
11,47 ລ້ານ
Avg. vol.
21,07 ພັນ
Volume
49,07 ພັນ
52-wk high
US$72,60
52-wk low
US$9,25
EPS
US$-47,40
Beta
3,30
Shares outstanding
1,11 ລ້ານ
No. of employees
22
News stories
From web sources and news partners
Investing.com Canada
·
9 ຊົ່ວໂມງກ່ອນ
Rodman & Renshaw reiterates Buy on Jasper Therapeutics stock By Investing.com
Investing.com
·
13 ຊົ່ວໂມງກ່ອນ
Piper Sandler cuts Jasper Therapeutics stock price target to $44
GuruFocus
·
1 ມື້ກ່ອນ
Jasper Therapeutics Reports Q3 2026 Earnings: GAAP EPS of -$4.80
Investing.com
·
1 ມື້ກ່ອນ
Jasper Therapeutics earnings missed by $7.79, revenue fell short of estimates
About Jasper Therapeutics Inc
CEO-
Employees22
Founded-
HeadquartersRedwood City, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websitejaspertx.com